AU2003280285A1 - Gucy1b2 genetic markers for ldl cholesterol response to statin therapy - Google Patents

Gucy1b2 genetic markers for ldl cholesterol response to statin therapy

Info

Publication number
AU2003280285A1
AU2003280285A1 AU2003280285A AU2003280285A AU2003280285A1 AU 2003280285 A1 AU2003280285 A1 AU 2003280285A1 AU 2003280285 A AU2003280285 A AU 2003280285A AU 2003280285 A AU2003280285 A AU 2003280285A AU 2003280285 A1 AU2003280285 A1 AU 2003280285A1
Authority
AU
Australia
Prior art keywords
gucy1b2
genetic markers
ldl cholesterol
statin therapy
cholesterol response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003280285A
Other versions
AU2003280285A8 (en
Inventor
Bradley J. Dain
Chad Messer
Carol R. Reed
Ping Zhan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Publication of AU2003280285A1 publication Critical patent/AU2003280285A1/en
Publication of AU2003280285A8 publication Critical patent/AU2003280285A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003280285A 2002-06-28 2003-06-30 Gucy1b2 genetic markers for ldl cholesterol response to statin therapy Abandoned AU2003280285A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39281802P 2002-06-28 2002-06-28
US60/392,818 2002-06-28
PCT/US2003/020606 WO2004003167A2 (en) 2002-06-28 2003-06-30 Gucy1b2 genetic markers for ldl cholesterol response to statin therapy

Publications (2)

Publication Number Publication Date
AU2003280285A1 true AU2003280285A1 (en) 2004-01-19
AU2003280285A8 AU2003280285A8 (en) 2004-01-19

Family

ID=30000940

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003280285A Abandoned AU2003280285A1 (en) 2002-06-28 2003-06-30 Gucy1b2 genetic markers for ldl cholesterol response to statin therapy

Country Status (2)

Country Link
AU (1) AU2003280285A1 (en)
WO (1) WO2004003167A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1784504A2 (en) * 2004-07-21 2007-05-16 Institut National De La Sante Et De La Recherche Medicale (Inserm) Oatp-c gene c463a polymorphism underlies variable response of statin therapy

Also Published As

Publication number Publication date
WO2004003167A2 (en) 2004-01-08
WO2004003167A3 (en) 2005-02-10
AU2003280285A8 (en) 2004-01-19

Similar Documents

Publication Publication Date Title
AU2003294828A1 (en) Specific markers for pancreatic cancer
AU2003205950A1 (en) Placement of alternative advertisements
AU2003219750A1 (en) Panel system
AU2003231100A1 (en) Embossed-in-register panel system
AU2003253535A1 (en) N-4-piperidinyl compounds as ccr5 modulators
AU2003213846A1 (en) Optimization of crossover points for directed evolution
AU2002238814A1 (en) Provision of location information
AU2003244359A1 (en) Trading support system
AU2003268028A1 (en) System for controlling insects
AUPS160602A0 (en) Therapeutic method
AU2003277910A1 (en) Ocular gene therapy
AUPS329602A0 (en) Fertilisation of soil
AU2002952938A0 (en) System for Conducting Clinical Trials
AU2003299100A1 (en) Pyrimidine compounds as therapeutic agents
AU2003215895A1 (en) Controlled-deformation panel
EP1646834A1 (en) Condensor
AU2003215150A1 (en) Therapeutic compounds
AU2003211345A1 (en) Optimum service selection assisting system
AU2003211022A1 (en) Aminodiphosphonate apolipoprotein e modulators
AU2002951908A0 (en) Medical demonstration
AUPS213802A0 (en) Disaccharides for drug discovery
EP1639300B8 (en) Heating panel for a heating system of floating structure
AU2001292301A1 (en) Novel drugs for liver diseases
AU2003280285A1 (en) Gucy1b2 genetic markers for ldl cholesterol response to statin therapy
AU2003284111A1 (en) Itgb3 gene haplotypes and atorvastatin dose effects on hdl cholesterol

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase